Tomorrow: The Kinds of Fluency That Make Communicators More Effective


Hi!

A reminder that tomorrow’s June Comm Convo will explore how life science communicators "speak" finance, science, and strategy, and what that fluency informs in our work.

June Comm Convo: Fluent in Finance, Science, and Strategy

📅 Tuesday, June 30th (tomorrow!)
⏰ 12-1 p.m. ET / 9-10 a.m. PT / 5-6 p.m. BST
📍 Zoom
🎟️ RSVP here. Complimentary for T2B Pro and Student members / $40 for Basic members.

Please note that this will definitely not be a “finance and science 101” session. We’ll focus on how fluency gets built in practice, how it changes the quality of counsel, and how it affects relationships as a company grows, raises capital, moves through the clinic, and faces more scrutiny.

What we’ll discuss

  • How communicators build enough depth across functions to ask better questions
  • What cross-functional credibility looks like from the other side of the table
  • How financial and scientific literacy changes the way comms advises through data, financing, corporate milestones, and higher-stakes moments
  • How the internal relationship map shifts as a company moves through different stages of growth and maturity
  • What becomes possible when communicators can proactively connect investor, scientific, media, employee, and leadership implications

Featured speakers

💬 Naina Bhasin, Ph.D., Chief Operating Officer, Lifordi Immunotherapeutics

💬 Julie DiCarlo, Head of Investor Relations & Communications, Rapport Therapeutics

💬 Chris Patil, Ph.D., Vice President, Media, BioAge Labs

💬 Peggy Vorwald, Ph.D., Executive Director, IR and Corporate Communications, Caribou Biosciences (moderator)

Our guest speakers collectively bring perspectives from company building, IR, science, media, operations, and corporate communications to this conversation about what fluency really requires and what it changes once you have it.

Hope to see you tomorrow!

Lynnea

T2B Monthly

Read more from T2B Monthly

T2B Monthly | June 2026 Hi! You tell me. Are we creating magic? That's how one of our forum speakers summed up T2B. To pursue a career as a biopharma communicator requires intention, grit, and high EQ. So, despite working in an industry steered by data, I'd agree that convening this community (all of you!) – across coast-to-coast meetups, our second annual forum, member-led virtual sessions – is a privilege, and yes, a little magical. ✨ Today's email is 2,604 words, a 9-minute read. In this...

Hi! You don't need me to tell you that there's an ongoing, major, major shift in healthcare media. One of the most prominent changes we're seeing right now is more journalists leaving traditional newsrooms to launch independent newsletters, podcasts, and subscriber-supported publications of their own. For us communicators, that raises important questions: How are reporters finding stories? What does credibility look like outside traditional media brands? How are these new publications going...

Hi! Last month, our Reaching and Valuing Every Generation Comm Convo explored how generational dynamics influence the way we communicate, collaborate, and build trust across the industry. Our panel of corporate affairs leaders -- all at different career stages -- examined how communicators can better engage stakeholders across generations, challenge assumptions about age and experience, and build stronger, more inclusive teams. Our top 10 takeaways: 1. Treat generational stereotypes as a...